Respiratory Devices Market Set to Reach US$ 49.90 Billion by 2033, Led by North America | Major Players:- Fisher & Paykel Healthcare Limited, ResMed

DataM Intelligence has released a new research report titled "Respiratory Devices Market Size 2026". The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the global United States Menswear Market.

Ready to scale in the United States Menswear Market? Connect with the right partners and unlock new growth opportunities today:-https://www.datamintelligence.com/partner-identification-enquiry/respiratory-devices-market?prtk

The global Respiratory Devices Market size reached US$ 23.45 Billion in 2024 and is expected to reach US$ 49.90 Billion by 2033, growing at a CAGR of 8.8% during the forecast period 2025-2033.

The Respiratory Devices Market refers to the global industry involved in the development, production, and distribution of medical devices used to diagnose, treat, and monitor respiratory disorders such as asthma, chronic obstructive pulmonary disease, and sleep apnea.
It includes products like ventilators, nebulizers, oxygen concentrators, inhalers, and CPAP devices that support breathing and improve lung function in both acute and chronic care settings.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/respiratory-devices-market?prtk

Key Industry Developments

United States-
✅ February 2026: ResMed announced the expansion of its cloud-connected respiratory care ecosystem, integrating AI-driven patient monitoring into its AirSense platform, improving remote therapy adherence tracking and sleep apnea management outcomes.

✅ January 2026: Philips Healthcare provided an update on its respiratory care portfolio, highlighting ongoing remediation and relaunch progress of CPAP and BiPAP devices in the U.S. market, alongside enhanced safety testing and regulatory compliance measures.

✅ December 2025: Medtronic launched an advanced ventilator software upgrade in the U.S., enabling improved patient-ventilator synchrony and enhanced monitoring capabilities for critical care settings.

Global-

✅ March 2026: Fisher & Paykel Healthcare introduced a next-generation humidified high-flow therapy system globally, designed to enhance respiratory support in ICU and homecare environments with improved oxygen delivery efficiency.

✅ February 2026: GE HealthCare expanded its respiratory diagnostics portfolio with AI-enabled imaging solutions to support early detection of chronic respiratory diseases such as COPD and lung fibrosis.

✅ January 2026: Drägerwerk AG launched an upgraded intensive care ventilator platform globally, focusing on neonatal and pediatric respiratory support with enhanced precision ventilation modes.

✅ November 2025: Masimo Corporation expanded its remote patient monitoring solutions, integrating respiratory rate tracking and pulse oximetry for home-based care, supporting post-acute respiratory disease management.

Strategic Acquisitions & Partnerships

✅ ResMed - Strategic Partnership
(March, 2026)
ResMed announced an expanded digital health partnership with Microsoft to enhance cloud-connected respiratory care platforms using AI-driven patient monitoring. The collaboration focuses on improving remote management of sleep apnea and COPD patients through scalable data infrastructure and predictive analytics.

✅ Philips - Expansion / Strategic Partnership
(February, 2026)
Philips strengthened its respiratory care portfolio through an extended collaboration with Masimo, integrating advanced patient monitoring technologies into ventilators and non-invasive respiratory devices. This move supports hospital demand for integrated critical care solutions.

✅ GE HealthCare - Acquisition
(January, 2026)
GE HealthCare completed the acquisition of a respiratory diagnostics and monitoring solutions provider (bolt-on acquisition within its patient care solutions segment). The deal enhances GE's capabilities in respiratory monitoring and aligns with its strategy to expand ICU and critical care device offerings.

✅ Medtronic - Strategic Partnership
(November, 2025)
Medtronic entered a collaboration with Cosmo Pharmaceuticals to integrate AI-assisted imaging and diagnostic capabilities into pulmonary procedures. The partnership strengthens Medtronic's respiratory intervention portfolio, particularly in minimally invasive lung diagnostics.

Strategic Leadership Analysis: Top Key Players in Respiratory Devices Market 2026

- Fisher & Paykel Healthcare Limited: Strong in respiratory care, humidification, masks, and homecare ventilation, with a deep focus on CPAP, acute care, and hospital respiratory solutions. The company's strength comes from patient comfort, therapy adherence, and a broad respiratory product portfolio.

- ResMed: A global leader in sleep apnea and respiratory care devices, especially cloud-connectable CPAP and bilevel systems. Its advantage is its combination of devices, masks, and digital care software for home-based respiratory management.

- Koninklijke Philips N.V.: A major respiratory care player with non-invasive ventilators, CPAP/BiPAP systems, and home oxygen therapy solutions. Philips stands out for connected care and AI-enabled digital platforms that link hospital and home respiratory support.

- GE HealthCare: Focuses on advanced respiratory monitoring and critical care systems used in hospitals and clinical environments. Its key value is integration of monitoring, diagnostics, and data-driven care for respiratory management.

- Medtronic: Recognized as one of the leading respiratory care market players, with strength in hospital-based critical care and ventilatory support solutions. The company benefits from its large clinical footprint and broad medical device presence.

- Drägerwerk AG & Co. KGaA: Offers medical ventilation, anesthesia workstations, neonatal care systems, and a broad respiratory protection portfolio. Its market position is reinforced by strong expertise in both hospital respiratory systems and protective breathing equipment.

Speak to Our Analyst and Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/respiratory-devices-market?prtk

Main Drivers and Trends Shaping the Future of Respiratory Devices Market-

Rising Burden of Chronic Respiratory Diseases: Increasing prevalence of conditions such as Chronic Obstructive Pulmonary Disease, asthma, and sleep apnea is a primary growth driver. Companies like ResMed and Philips Healthcare highlight growing patient pools in their annual reports, directly boosting demand for ventilators, CPAP, and oxygen therapy devices.

Aging Population and Vulnerability to Lung Disorders: The global rise in geriatric populations more prone to respiratory illnesses has increased long-term demand for homecare respiratory solutions. Medtronic emphasizes elderly care as a key revenue contributor in its respiratory portfolio.

Expansion of Home Healthcare & Remote Monitoring: There is a strong shift from hospital-based care to home-based respiratory support. Firms like GE HealthCare and Fisher & Paykel Healthcare report increased adoption of portable ventilators and oxygen concentrators, driven by cost efficiency and patient convenience.

Technological Advancements in Devices: Continuous innovations such as AI-enabled ventilators, smart inhalers, and connected CPAP machines are improving treatment outcomes. ResMed has integrated cloud-based monitoring platforms, while Philips Healthcare focuses on digital respiratory care ecosystems.

Impact of Pandemic Preparedness and ICU Infrastructure Growth: Post-COVID-19, governments and hospitals are strengthening ICU capacities and stockpiling ventilators. This has led to sustained procurement pipelines, as noted in disclosures from Drägerwerk.

Increasing Air Pollution and Lifestyle Factors: Rising pollution levels, especially in urban regions, are contributing to respiratory complications. This trend is acknowledged by World Health Organization, indirectly driving demand for respiratory support and monitoring devices.

Growing Awareness and Early Diagnosis: Public health campaigns and improved diagnostic capabilities are increasing early detection rates of respiratory diseases, thereby expanding the treatment population and device usage.

Favorable Reimbursement Policies in Developed Markets: Supportive reimbursement frameworks in regions like North America and Europe are encouraging patients to adopt advanced respiratory therapies, as reflected in strategic updates from Invacare Corporation.

Respiratory Devices Market - Regional Insights

North America: 40.43% (Largest share, driven by advanced healthcare infrastructure and strong U.S. dominance).
The region leads the global market primarily due to the United States, which accounts for the majority share within North America. High prevalence of respiratory diseases (COPD, asthma, sleep apnea), strong reimbursement systems, and early adoption of advanced technologies (e.g., CPAP, ventilators) significantly drive demand. Additionally, high healthcare spending and a large aging population further strengthen market leadership.

Europe: 28% (Second-largest share, supported by strong healthcare systems and aging population).
Europe maintains a significant share due to well-established public healthcare systems, increasing respiratory disease burden, and rising elderly population. Government initiatives and preventive healthcare focus also contribute to steady adoption of respiratory devices across countries like Germany, the UK, and France.

Asia Pacific: 26% (Fastest growing, driven by expanding healthcare access and strong demand in Japan, China, and India).
The region is experiencing the highest growth, led by countries such as Japan, China, and India. In Japan specifically, growth is driven by a rapidly aging population, high prevalence of chronic respiratory diseases, and strong adoption of technologically advanced devices supported by government subsidies. Rising pollution levels, increasing healthcare investments, and a growing middle-class population further accelerate regional expansion.

Middle East & Africa: 11% (Emerging market, driven by improving healthcare infrastructure).
Growth in this region is supported by increasing healthcare investments, rising awareness of respiratory diseases, and gradual expansion of medical facilities. However, affordability and limited access to advanced devices still restrain faster adoption.

Purchase Corporate License | Market Intelligence:https://www.datamintelligence.com/buy-now-page?report=respiratory-devices-market?prtk

Market Segmentation Analysis:

By Product Type

The respiratory devices market is categorized into therapeutic devices, monitoring devices, diagnostic devices, consumables & accessories, and others. Therapeutic devices dominate the segment as they are widely used for treatment purposes, including ventilators, inhalers, and oxygen concentrators that help patients manage breathing disorders. Monitoring devices, such as pulse oximeters and capnographs, play a crucial role in tracking respiratory parameters and ensuring timely medical intervention. Diagnostic devices are used to identify respiratory conditions through tests like spirometry and imaging. Consumables and accessories, including masks, tubing, and filters, are essential for the proper functioning of respiratory systems and generate recurring demand. The "others" category includes emerging or niche respiratory technologies.

By Application/Indication

Based on application, the market is segmented into chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, pneumonia, cystic fibrosis, bronchitis, and others. COPD holds a significant share due to its high global prevalence and long-term treatment requirement. Asthma is another major segment, driven by increasing environmental pollution and lifestyle changes. Sleep apnea is witnessing rapid growth due to rising awareness and diagnosis rates, especially with the adoption of CPAP devices. Pneumonia and bronchitis contribute notably due to seasonal and infection-related cases. Cystic fibrosis, although less common, requires specialized and continuous respiratory care. The "others" segment includes rare respiratory disorders and acute conditions requiring short-term device use.

By Portability (Stationary Devices, Portable Devices),

By End-User (Hospitals, Homecare Settings, Ambulatory Surgical Centers (ASCs), Clinics, Emergency Medical Services (EMS)/Transport, and Others)

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTW

Contact:
Fabian
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, DataM Intelligence 4market Research LLP, Lalitha Nagar, Habsiguda, Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
UK: +44 161-870-5507
Email: fabian@datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to provide swift and astute solutions to clients like you. We encompass a multitude of syndicated reports and customized reports with a robust methodology.

This release was published on openPR.